Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8655)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 27, 2016 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jakhetiya A, Garg PK, Prakash G, Sharma J, Pandey R, Pandey D. Targeted therapy of gastrointestinal stromal tumours. World J Gastrointest Surg 2016; 8(5): 345-352 [PMID: 27231512 DOI: 10.4240/wjgs.v8.i5.345] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v8/i5/345.htm |
| Number | Citing Articles |
| 1 |
Jens C. Hahne, Nicola Valeri. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00226
|
| 2 |
D. D. Khalikov, F. Sh. Akhmetzyanov, S. V. Petrov. Clinical and morphological characteristics of gastrointestinal stromal tumors. Arkhiv patologii 2017; 79(4): 48 doi: 10.17116/patol201779448-55
|
| 3 |
Qun Zhao, Yong Li, Peigang Yang, Yanqiu Zang, Liqiao Fan, Bibo Tan, Yuan Tian. Evaluation for therapeutic measures to small gastric stromal tumor: A retrospective study of 90 cases. Current Problems in Cancer 2018; 42(1): 107 doi: 10.1016/j.currproblcancer.2018.01.012
|
| 4 |
Peter S. Liu, Hero K. Hussain, Harris L. Cohen, Randall L. Scott, Mahmoud M. Al-Hawary, Neil J. Hansen, David H. Kim, Meghan G. Lubner, Ryan B. O’Malley, Justin M. Ream, Julie A. Ruma, Erica B. Stein, Shane Wells. . 2017; doi: 10.54057/cpi.gi2017
|
| 5 |
Sara D'Aronco, Edoardo D'Angelo, Sara Crotti, Pietro Traldi, Marco Agostini. New Mass Spectrometric Approaches for the Quantitative Evaluation of Anticancer Drug Levels in Treated Patients. Therapeutic Drug Monitoring 2019; 41(1): 1 doi: 10.1097/FTD.0000000000000573
|
| 6 |
Chiara Platella, Ettore Napolitano, Claudia Riccardi, Domenica Musumeci, Daniela Montesarchio. Disentangling the Structure–Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs. Journal of Medicinal Chemistry 2021; 64(7): 3578 doi: 10.1021/acs.jmedchem.1c00125
|
| 7 |
Ke-Cheng Ju, Bin Zhang, Yi-Lin Hu, Ying Feng, Xiao-Hong Li, Yi-Fei Liu, Peng Li, Qin-Sheng Mao, Wan-Jiang Xue. High expression of G protein subunit gamma 13 is associated with poor prognosis of gastrointestinal stromal tumor. Pathology - Research and Practice 2020; 216(10): 153143 doi: 10.1016/j.prp.2020.153143
|
| 8 |
Vitor Ottoboni Brunaldi, Martin Coronel, Danielle Azevedo Chacon, Eduardo Turiani Hourneaux De Moura, Sérgio E. Matuguma, Eduardo Guimarães Hourneaux De Moura, Diogo Turiani Hourneaux De Moura. Subepithelial rectal gastrointestinal stromal tumor – the use of endoscopic ultrasound-guided fine needle aspiration to establish a definitive cytological diagnosis: a case report. Journal of Medical Case Reports 2017; 11(1) doi: 10.1186/s13256-017-1205-7
|
| 9 |
Priya Gopie, Lin Mei, Anthony C Faber, Steven R Grossman, Steven C Smith, Sosipatros A Boikos. Classification of gastrointestinal stromal tumor syndromes. Endocrine-Related Cancer 2018; 25(2): R49 doi: 10.1530/ERC-17-0329
|
| 10 |
Jin Hyung Lee. Hemoperitoneum Caused by a Spontaneously Ruptured Gastrointestinal Stromal Tumor with Cystic Degeneration. Soonchunhyang Medical Science 2017; 23(1): 52 doi: 10.15746/sms.17.012
|
| 11 |
Mónica Ballesteros, Nadia Montero, Antonio López-Pousa, Gerard Urrútia, Ivan Solà, Gabriel Rada, Hector Pardo-Hernandez, Xavier Bonfill. Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST). BMC Medical Research Methodology 2017; 17(1) doi: 10.1186/s12874-017-0402-9
|
| 12 |
Lin Mei, Wei Du, Michael Idowu, Margaret von Mehren, Sosipatros A. Boikos. Advances and Challenges on Management of Gastrointestinal Stromal Tumors. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00135
|
| 13 |
Sara D'Aronco, Eleonora Calandra, Sara Crotti, Giuseppe Toffoli, Elena Marangon, Bianca Posocco, Pietro Traldi, Marco Agostini. Field-Assisted Paper Spray Mass Spectrometry for the Quantitative Evaluation of Imatinib Levels in Plasma. European Journal of Mass Spectrometry 2016; 22(5): 217 doi: 10.1255/ejms.1437
|
| 14 |
Ke Li, Haibo Cheng, Zhang Li, Yuzhi Pang, Xiaona Jia, Feifei Xie, Guohong Hu, Qingping Cai, Yuexiang Wang. Genetic progression in gastrointestinal stromal tumors: mechanisms and molecular interventions. Oncotarget 2017; 8(36): 60589 doi: 10.18632/oncotarget.16014
|
| 15 |
Mekala Gunaratnam, Gavin W. Collie, Anthony P. Reszka, Alan K. Todd, Gary N. Parkinson, Stephen Neidle. A naphthalene diimide G-quadruplex ligand inhibits cell growth and down-regulates BCL-2 expression in an imatinib-resistant gastrointestinal cancer cell line. Bioorganic & Medicinal Chemistry 2018; 26(11): 2958 doi: 10.1016/j.bmc.2018.04.050
|
| 16 |
Katharina Klose, Eva‐Maria Packeiser, José‐Luis Granados‐Soler, Marion Hewicker‐Trautwein, Hugo Murua Escobar, Ingo Nolte. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines. Veterinary and Comparative Oncology 2022; 20(3): 641 doi: 10.1111/vco.12817
|
| 17 |
Robert J. Ferguson, Jessica Manculich, Hsuan Chang, Nikita J. Sareen, Beth E. Snitz, Lauren Terhorst, Dana H. Bovbjerg, Anette U. Duensing. Self‐reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey. Cancer 2022; 128(22): 4017 doi: 10.1002/cncr.34469
|
| 18 |
Elizabeta Popa, Felice Schnoll‐Sussman, Arun Jesudian, Govind Nandakumar, Manish A. Shah. Textbook of Uncommon Cancer. 2017; : 395 doi: 10.1002/9781119196235.ch27
|
| 19 |
Annick D. Van den Abbeele, Christopher G. Sakellis, Suzanne George. Nuclear Medicine and Molecular Imaging. 2022; : 238 doi: 10.1016/B978-0-12-822960-6.00110-1
|
| 20 |
Pierre Vandenberghe, Marine Delvaux, Perrine Hagué, Christophe Erneux, Jean-Marie Vanderwinden. Potentiation of imatinib by cilostazol in sensitive and resistant gastrointestinal stromal tumor cell lines involves YAP inhibition. Oncotarget 2019; 10(19): 1798 doi: 10.18632/oncotarget.26734
|
| 21 |
Nirali Pandya, Amit Kumar. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-01529-3
|
| 22 |
Hao Wu, Yao Wang, Jia-Tao Chen, Li-Ping Wang, Gui-Rong Liu, Shu-Lin Liu. Anticancer effects of dietary administration of secoisolariciresinol diglucoside in a patient of gastrointestinal stromal tumor: a case report. International Journal of Surgery Oncology 2020; 5(6): e103 doi: 10.1097/IJ9.0000000000000103
|
| 23 |
Marina Gorelik, Braulio Sabates, Adel Elkbuli, Tony Dunne. Ileal GIST presenting with bacteremia and liver abscess: A case report and review of literature. International Journal of Surgery Case Reports 2018; 42: 261 doi: 10.1016/j.ijscr.2017.12.033
|
| 24 |
Geng Chia Ku, Abygail G. Chapdelaine, Marina K. Ayrapetov, Gongqin Sun. Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells. Cancers 2022; 14(16): 4027 doi: 10.3390/cancers14164027
|
| 25 |
Jinbao Wu, Changjuan Wang, Xia Cui, Lin Liu, Lu Wang, Jing Wang, Xiaohui Xue, Tong Dang. MicroRNA-128 acts as a suppressor in the progression of gastrointestinal stromal tumor by targeting B-lymphoma Mo-MLV insertion region 1. Clinical and Translational Oncology 2023; 26(2): 363 doi: 10.1007/s12094-023-03354-8
|
| 26 |
P D Dunaev, S V Boichuk, A R Galembikova, R R Khusnutdinov. Establishment of imatinib-resistant gastrointestinal stromal tumor cell subline and investigation of its sensitivity to the chemomotherapeutic agents. Kazan medical journal 2017; 98(6): 993 doi: 10.17750/KMJ2017-993
|
| 27 |
Abygail G. Chapdelaine, Gongqin Sun. Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer. Biomolecules 2023; 13(8): 1207 doi: 10.3390/biom13081207
|
| 28 |
Matthew W Rosenbaum, Raul S Gonzalez. Targeted therapy for upper gastrointestinal tract cancer: current and future prospects. Histopathology 2021; 78(1): 148 doi: 10.1111/his.14244
|